References
- Akslen LA, Myking AO, Salvesen H, Varhaug JE. Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur J Cancer 1992; 29A: 44–51.
- Cady B, Sedgwick CE, Meissner WA, et al. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 1976; 184: 541–553.
- Carcangiu ML, Zampi G, Pupi A, et al. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985; 55: 805–828.
- DeGroot LJ, Reilly M. Comparison of 30- and 50-mCi doses of iodine-131 for thyroid ablation. Ann Intern Med 1982; 96: 51–53.
- Grant CS, Hay ID, Gough IR, et al. Local recurrence in papillary thyroid carcinoma: Is extent of surgical resection important? Surgery 1988; 104: 954–962.
- Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer 1985; 56: 531–538.
- Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commen-tary on the second edition. Cancer 1989; 63: 908–911.
- Mazzaferri EL. Impact of initial tumor features and treatment selected on the long-term course of differ-entiated thyroid cancer. Thyroid Today 1995; 18: 1–13.
- Mazzaferri EL, Young RU, Oertel JE, et al. Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine 1977; 56: 171–196.
- McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, ther-apy, and outcome. Mayo Clin Proc 1986; 61: 978–996.
- Noguchi S, Yamashita H, Murakami N, et al. Small carcinomas of the thyroid. A long-term follow-up of 867 patients. Arch Surg 1996; 131: 187–191.